» Articles » PMID: 35671306

Evaluation of Subclinical Ventricular Systolic Dysfunction Assessed Using Global Longitudinal Strain in Liver Cirrhosis: A Systematic Review, Meta-analysis, and Meta-regression

Overview
Journal PLoS One
Date 2022 Jun 7
PMID 35671306
Authors
Affiliations
Soon will be listed here.
Abstract

Global longitudinal strain (GLS) can identify subclinical myocardial dysfunction in patients with cirrhosis. This systematic review aims to provide evidence of a possible difference in GLS values between patients with cirrhosis and patients without cirrhosis. Studies from inception to August 11, 2021, were screened and included based on the inclusion criteria. The Newcastle Ottawa Scale was used to assess the quality of nonrandomized studies. Meta-analyses were conducted with subsequent sensitivity and subgroup analyses according to age, sex, cirrhosis etiology, and severity. Publication bias was evaluated using Begg's funnel plot, Egger's test, and rank correlation test with subsequent trim-and-fill analysis. The systematic database search yielded 20 eligible studies. Random effect showed a significant reduction of left ventricular (LV) GLS (MD:-1.43;95%; 95%CI,-2.79 to -0.07; p = 0.04; I2 = 95% p<0.00001) and right ventricular (RV) GLS (MD:-1.95; 95%CI,-3.86 to -0.05, p = 0.04; I2 = 90%, p<0.00001) in the group with cirrhosis. A sensitivity test on subgroup analysis based on the study design showed a -1.78% lower LV-GLS in the group with cirrhosis (I2 = 70%, p = 0.0003). Meta-regression analysis showed that the severity of cirrhosis was significantly related to GLS reduction. This research received no specific grants from any funding agency in the public, commercial, or not-for-profit sectors. The study protocol was registered at PROSPERO (CRD42020201630). We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement guidelines.

Citing Articles

Association between vitamin D receptor gene polymorphism and essential hypertension: An updated systematic review, meta-analysis, and meta-regression.

Dakota I, Addai M, Maulana R, Ivan I, Sukmawan R, Widyantoro B PLoS One. 2024; 19(12):e0314886.

PMID: 39715198 PMC: 11666036. DOI: 10.1371/journal.pone.0314886.


Pediatric cirrhotic cardiomyopathy: literature review and effect size estimations of selected parameters.

Niculae A, Cainap S, Grama A, Pop T Eur J Pediatr. 2024; 183(11):4789-4797.

PMID: 39227507 PMC: 11473602. DOI: 10.1007/s00431-024-05746-6.


The Contemporary Role of Speckle Tracking Echocardiography in Cirrhotic Cardiomyopathy.

Dimitroglou Y, Aggeli C, Alexopoulou A, Tsartsalis D, Patsourakos D, Koukos M Life (Basel). 2024; 14(2).

PMID: 38398688 PMC: 10890501. DOI: 10.3390/life14020179.

References
1.
Chen Y, Chan A, Chan S, Chok S, Sharr W, Fung J . A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation. J Cardiol. 2015; 67(2):140-6. DOI: 10.1016/j.jjcc.2015.08.001. View

2.
Mechelinck M, Hartmann B, Hamada S, Becker M, Andert A, Ulmer T . Global Longitudinal Strain at Rest as an Independent Predictor of Mortality in Liver Transplant Candidates: A Retrospective Clinical Study. J Clin Med. 2020; 9(8). PMC: 7464171. DOI: 10.3390/jcm9082616. View

3.
Izzy M, VanWagner L, Lin G, Altieri M, Findlay J, Oh J . Redefining Cirrhotic Cardiomyopathy for the Modern Era. Hepatology. 2019; 71(1):334-345. PMC: 7288530. DOI: 10.1002/hep.30875. View

4.
Novo G, Macaione F, Giannitrapani L, Minissale M, Bonomo V, Indovina F . Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study. Aliment Pharmacol Ther. 2018; 48(7):740-749. DOI: 10.1111/apt.14934. View

5.
Demirtas Inci S, Sade L, Altin C, Pirat B, Pamukcu H, Yilmaz S . Subclinical myocardial dysfunction in liver transplant candidates determined using speckle tracking imaging. Turk Kardiyol Dern Ars. 2019; 47(8):638-645. DOI: 10.5543/tkda.2019.94728. View